These Guidelines by the Scientific Committee on Health, Environmental and Emerging Risks (SCHEER) concern guidance on how to perform benefit-risk assessment of phthalates used in certain medical devices. Deadline for comments is 29 April 2019.
Simona Martin, Scientific Officer at the European Commission Joint Research Centre, talks about the new European Platform on Rare Disease Registration launched at the occasion of Rare Disease Day on February 28.
Carina Dantas, Innovation Director at Cáritas Coimbra, explains why her organisation is an active member of the EU Health Policy Platform and hosted one of the platform's previous cycle of thematic networks, Smart Healthy Age-Friendly Environments (SHAFE).
The conference will bring together patients, advocacy groups, leading professionals, transplant agencies, national authorities as well as EU institutions for a unique exchange of views on their common aim: increasing organ donation and transplantation in the EU. EUDONORGAN is a project funded by the EU.
The meeting will be an opportunity for the representatives of Member States, the EIB and several European Commission services to discuss a wide range of public health policies and initiatives. On 15 February, the Steering Group will hold its first joint meeting with the Horizon2020 Programme Committee.
The Joint Action on Tobacco Control is a 3-year action (2017 – 2020), with a budget of EUR 2.5 million under the EU Health Programme 2014-2020. The Joint Action aims to support Member States in the implementation of the Tobacco Products Directive (TPD).
Veronica Manfredi, Director of the European Commission’s Quality of Life Directorate at the Directorate General Environment, talks about EU measures to reduce air pollution and its impact on health, an issue in the global spotlight.
At the request of the European Commission, the preliminary guidelines on the benefit-risk assessment of the presence of phthalates in certain medical devices are covering phthalates, which are carcinogenic, mutagenic, toxic to reproduction (CMR) or have endocrine-disrupting (ED) properties. Deadline for registration: 6 March 2019.
The purpose of the training is to provide support on strategies and actions promoting and strengthening the prudent use of antimicrobials and monitoring resistance in veterinary, food safety and public health sectors, to reinforce engagement with international organisations, and intensify cooperation with the invited countries.
The EU-funded project EUDONORGAN will hold its next conference titled “Why Organ Donation Matters to Us All” on Monday, 18 February in Brussels. The event is open to all interested organisations and individuals.
Last places available: register to the event!